Clinical trial
Improvement of Erectile Dysfunction by Fluvastatin in Patients With…
NCT00382161 · University Hospital, Saarland, Other · Withdrawn
Key facts
| NCT number | NCT00382161 |
|---|---|
| Title | Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors |
| Official title | Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction |
| Lead sponsor | University Hospital, Saarland, Other |
| Collaborators | Novartis Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Impotence |
| Intervention type | Drug |
| Interventions | Fluvastatin-sodium |
| Enrollment | 20 |
| Start date | Oct 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Sep 28, 2006 |
| Last update posted | Feb 13, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: